The most common mistake people make when shopping for weight loss medication online is starting with the drug name instead of the provider’s pricing model. Someone searches “cheapest semaglutide” and ends up on a platform with a $99 drug fee and a $199/month coaching membership they didn’t notice until checkout. Total cost, pharmacy transparency, and shipping logistics matter as much as the headline number.
Here is a decision framework first, then the providers mapped against it.
How to Actually Compare These Platforms
Price per month (all-in). Add the platform fee, the medication cost, and any required labs or coaching. Some brands advertise a medication price but bury a mandatory membership.
Pharmacy credentials. Compounded GLP-1s are not FDA-approved drugs. The question is whether the compounding pharmacy is 503A-licensed, USP-797 compliant, and independently certified. A named, verifiable pharmacy is a better sign than a vague “partnered facility.”
Speed and reach. Some platforms ship in 24 to 72 hours to all 50 states. Others are slower or have geographic gaps.
Clinical oversight level. Do you get a board-certified physician review, or a quick checkbox intake? How much follow-up is built in?
The 7 Providers
1. HealthRX
Before getting to the number, what stands out about HealthRX is how much supply-chain detail they publish. The compounding pharmacy is Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot tracking from bench to delivery. The platform also carries LegitScript certification (cert 50087439). That kind of named, auditable chain is not standard across this category.
Price-wise, compounded semaglutide starts at $99/month. Compounded tirzepatide starts at $149/month. Once-weekly injection. Free overnight shipping to all 50 states, no contracts. A US board-certified physician reviews the online health assessment within roughly 24 hours.
The clinical trial data HealthRX references is real: the SURMOUNT-1 trial showed tirzepatide participants losing around 21% of body weight at 72 weeks, and the STEP 1 trial showed roughly 15% loss at 68 weeks for semaglutide. HealthRX cites those numbers as context for the drug class, not as a promise of individual results.
Compounded medications are not FDA-approved. That caveat applies here and throughout this list.
2. Mochi Health
Mochi is notable for putting board-certified obesity-medicine clinicians in the prescribing seat rather than general practitioners. Compounded semaglutide runs around $99/month, tirzepatide around $199. Monitoring is more hands-on than most budget options. Good fit if you want clinical depth without paying a premium-tier price.
3. FormBlends
FormBlends is a compounded GLP-1 telehealth option with physician oversight and one feature that separates it from almost every competitor: published per-product purity data. Each batch shows HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results with actual numbers attached. For people who want that kind of documentation before injecting anything, this matters.
Cash pricing is higher than HealthRX, around $299 for semaglutide and $349 for tirzepatide per vial. The platform also carries a broad catalog of peptides for recovery, cognitive support, and longevity under the same clinician model, which makes it the logical pick for anyone who wants GLP-1 therapy and other peptides from one provider. Shipping reaches 47 states, not all 50.
FormBlends earns a spot on this list specifically for the purity testing and catalog width. If your top priority is lowest entry price and nationwide overnight shipping, HealthRX wins that comparison. If you want documented batch testing or a wider peptide menu, FormBlends is the better fit.
4. Henry Meds
Cash-pay compounded GLP-1s, fast 24 to 72 hour shipping. First-month costs typically fall in the $179 to $249 range. Lighter on monitoring than Mochi but faster on the intake-to-delivery timeline. Worth considering if you want speed and simplicity.
5. Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims & Hers moved from compounded to branded GLP-1 medications. Injectable Wegovy is listed around $299/month, oral semaglutide around $249, and Zepbound around $399. With insurance and a savings card, some users report costs as low as $0 to $25. Useful if you have insurance coverage you want to maximize.
6. Ro Body
Ro charges around $39 for the first month and $74 to $149/month after that, with medications billed separately. The platform has a prior-authorization team to help with insurance, which is a real differentiator for people dealing with insurer back-and-forth on branded meds.
7. PlushCare
At $19.99/month for membership, PlushCare is one of the lower platform fees on this list. It focuses on branded medications with insurance billing and offers same-day provider visits. A practical choice for someone already insured who needs fast access to a prescriber.
A Note Before You Decide
None of the compounded medications on this list are FDA-approved drugs. Individual weight loss results vary and depend on factors well beyond the medication itself. Prices and availability shift, so confirm current numbers directly with any provider before committing. This article reflects publicly available information as of mid-2026 and is not medical advice.
Common Questions
Does HealthRX’s $99/month price include everything, or are there hidden fees?
The $99/month covers compounded semaglutide and free overnight shipping with no contracts. There is no mandatory membership layered on top. Tirzepatide starts at $149/month under the same structure. Always confirm current pricing directly, since telehealth platforms adjust rates and the intake process will show the full cost before you commit.
What actually makes a compounding pharmacy legitimate, and how do I check?
Look for a 503A license, USP-797 compliance, and independent certification such as LegitScript. A named pharmacy you can search, like Manifest Pharmacy in Greer, South Carolina, is more verifiable than a vague “partner facility.” The FDA’s compounding pharmacy database and LegitScript’s public directory both let you confirm credentials before ordering.
After Hims & Hers stopped offering compounded GLP-1s in 2026, are branded options on that platform actually affordable?
For most cash-pay patients, no. Branded Wegovy runs around $299/month through Hims & Hers and Zepbound around $399. The platform becomes cost-effective only if you have insurance coverage and a manufacturer savings card, which some users have combined to bring costs to $0 to $25 per month.
Is FormBlends worth the higher price compared to HealthRX, or is the purity data marketing?
The batch-level HPLC purity percentages, mass spectrometry identity results, and endotoxin sterility data FormBlends publishes are real analytical outputs, not marketing language. Whether they justify paying roughly $299 versus $99 per month depends on how much documentation matters to you personally. For most cost-focused buyers, HealthRX is the better value. For anyone who wants to see actual lab numbers before injecting, FormBlends answers that question.
Can I use any of these providers if I live in a state with stricter telehealth prescribing rules?
Geographic coverage varies. HealthRX ships overnight to all 50 states. FormBlends reaches 47 states. Henry Meds, Mochi, Ro, and PlushCare each have their own coverage maps that shift as regulations change. Check the provider’s state eligibility page directly before completing an intake, because prescribing rules for compounded medications differ by state and have been tightening since early 2026.
Sources
- FDA: 503A Compounding Pharmacies overview (fda.gov)
- SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022 (tirzepatide weight loss outcomes)
- STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021 (semaglutide weight loss outcomes)
- LegitScript certification database (legitscript.com)
- Novo Nordisk compounding settlement coverage, Reuters, March 2026
- FDA warning letters to telehealth/compounding firms, January to March 2026 (fda.gov)
